Proposal to list medical devices supplied by MoveMe Health Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by MoveMe Health Limited (“MoveMe”) in Part III of Section H of the Pharmaceutical Schedule from 1 July 2022 through a non-exclusive provisional agreement.
We propose to list medical devices supplied in the following category:
- Rehabilitation equipment, patient positioning products and supports (“rehabilitation products”)
Consultation closes at 4pm Tuesday 10 May 2022 and feedback can be emailed to firstname.lastname@example.org.
What would the effect be?
From 1 July 2022 rehabilitation products supplied by MoveMe would be listed under a proposed national agreement for all DHB hospitals to purchase under, subject to consultation and approval by Pharmac’s board or delegate (“Agreement”).
The Agreement would not be for sole supply and DHBs can continue to purchase other suppliers’ brands of rehabilitation products.
The Agreement would supersede any existing DHB agreements with MoveMe for the medical devices included in the Agreement. Any medical device listed in the Agreement and purchased by a DHB would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing in the Pharmaceutical Schedule.
Pricing for the rehabilitation products in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- DHB clinical staff in a range of different clinical settings including but not limited to:
- Clinical engineers and maintenance services
- DHB procurement and supply chain
- Neurologists and Neurosurgeons
- Occupational therapists
- Orthopaedic surgeons
- Rehabilitation physicians (including spinal units)
- Speech-language therapists
- Suppliers and wholesalers
About the medical devices
Rehabilitation is the process of regaining strength or relearning skills after a serious injury, illness, or surgery. Rehabilitation crosses all age groups, though the type, level and goals of rehabilitation will differ depending on the individual needs. Rehabilitation often focuses on:
- physical therapy to help with strength, mobility, and fitness;
- occupational therapy to help with daily activities;
- speech-language therapy to help with speaking, understanding, reading, writing, and swallowing;
- cognitive therapy (following head injury); and
- treatment of pain.
Why we’re proposing this
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP, and proposals were progressed to contract negotiations to seek provisional agreements.
This proposal is the latest to arise from this process and we expect to consult on further provisional agreements with suppliers of rehabilitation products throughout 2022.
Details about our proposal
The proposal would result in listing 1709 rehabilitation products in the Pharmaceutical Schedule covering the following ranges:
The proposal does not include services for fitting or customising orthotics as this is not within the scope of Pharmac’s medical device remit. If DHBs were requiring these additional services from MoveMe they would need to use their current agreements or enter into separate arrangements.
Further information, including pricing and contractual details, has been provided to DHB Procurement personnel. Clinicians interested in further detail on what this change means for their DHB should engage with their Procurement teams.
To provide feedback
Send us an email: email@example.com by 4pm 10 May 2022.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.